Concepedia

A Double-blind, Randomized Phase lib Study Evaluating the Efficacy and Safety of Sorafenib (SOR) Compared to Placebo (PL) When Administered in Combination with Docetaxel And/or Letrozole in Patients with Metastatic Breast Cancer (MBC): FM-B07-01 Trial

Gabriella Mariani, Olga Burdaeva, Luís San Román, Dmitry Udovitsa, Pamela Driol, Giovanni Goisis, Claudio Zamagni, Semiglazov Vf, Luca Gianni

European Journal of Cancer · 2011 · 22 citations · 0 references

Concepts

Metastatic Breast CancerOncologyFm-b07-01 TrialBreast OncologyCancer ManagementPharmacologyClinical TrialsBreast CancerPharmacotherapyCancer TreatmentDrug TrialMedicineDocetaxel And/or Letrozole